157 related articles for article (PubMed ID: 21330931)
1. Impact of diabetes mellitus on long-term follow-up of percutaneous coronary intervention based on clinical presentation of coronary artery disease.
Ruperto C; Capodanno D; Blundo A; Capranzano P; Sanfilippo A; Caggegi A; Bucalo R; Giaimo V; Tamburino C
J Cardiovasc Med (Hagerstown); 2011 Jun; 12(6):405-10. PubMed ID: 21330931
[TBL] [Abstract][Full Text] [Related]
2. Comparison of one-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients with unprotected left main coronary artery disease and acute coronary syndromes (from the CUSTOMIZE Registry).
Caggegi A; Capodanno D; Capranzano P; Chisari A; Ministeri M; Mangiameli A; Ronsivalle G; Ricca G; Barrano G; Monaco S; Di Salvo ME; Tamburino C
Am J Cardiol; 2011 Aug; 108(3):355-9. PubMed ID: 21545992
[TBL] [Abstract][Full Text] [Related]
3. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
4. Unprotected left main stenting, short- and long-term outcomes.
Qarawani D; Menachem N; Ganem D; Hasin Y
Acute Card Care; 2010 Dec; 12(4):124-9. PubMed ID: 21039084
[TBL] [Abstract][Full Text] [Related]
5. Comparison of drug-eluting stents and bare-metal stents for the treatment of unprotected left main coronary artery disease in acute coronary syndromes.
Tamburino C; Di Salvo ME; Capodanno D; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S
Am J Cardiol; 2009 Jan; 103(2):187-93. PubMed ID: 19121434
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry.
Capodanno D; Di Salvo ME; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S; Tamburino C
Catheter Cardiovasc Interv; 2009 Feb; 73(3):310-6. PubMed ID: 19214964
[TBL] [Abstract][Full Text] [Related]
7. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
9. Impact of diabetes and acute coronary syndrome on survival in patients treated with drug-eluting stents.
Lee MS; Jurewitz D; Zimmer R; Pessegueiro A; Bhatia R; Currier J; Yeatman L; Tobis JM
Catheter Cardiovasc Interv; 2008 Dec; 72(7):909-14. PubMed ID: 19016467
[TBL] [Abstract][Full Text] [Related]
10. Early and long-term outcomes after surgical and percutaneous myocardial revascularization in patients with non-ST-elevation acute coronary syndromes and unprotected left main disease.
Buszman PP; Bochenek A; Konkolewska M; Trela B; Kiesz RS; Wilczyński M; Cisowski M; Krejca M; Banasiewicz-Szkróbka I; Krol M; Kondys M; Wiernek S; Orlik B; Martin JL; Tendera M; Buszman PE
J Invasive Cardiol; 2009 Nov; 21(11):564-9. PubMed ID: 19901409
[TBL] [Abstract][Full Text] [Related]
11. The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention).
Stefanini GG; Serruys PW; Silber S; Khattab AA; van Geuns RJ; Richardt G; Buszman PE; Kelbæk H; van Boven AJ; Hofma SH; Linke A; Klauss V; Wijns W; Macaya C; Garot P; Di Mario C; Manoharan G; Kornowski R; Ischinger T; Bartorelli AL; Gobbens P; Windecker S
J Am Coll Cardiol; 2011 May; 57(22):2221-32. PubMed ID: 21616282
[TBL] [Abstract][Full Text] [Related]
12. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes of the Drug-Eluting Stents in the Real World (DESIRE) Registry.
Sousa A; Costa JR; Moreira AC; Cano M; Maldonado G; Costa RA; Pavanello R; Romano ER; Campos C; Haddad N; Abizaid A; Feres F; Mattos LA; Staico R; Sousa JE;
J Interv Cardiol; 2008 Aug; 21(4):307-14. PubMed ID: 18754966
[TBL] [Abstract][Full Text] [Related]
15. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes.
Hayes KR; Applegate RJ; Sacrinty MT; Kutcher MA; Gandhi SK; Santos RM; Little WC
J Invasive Cardiol; 2010 Jun; 22(6):266-70. PubMed ID: 20516505
[TBL] [Abstract][Full Text] [Related]
16. [The impact of prior revascularization procedures on outcome of percutaneous coronary intervention in ACS].
Walkowicz W; Gasior Z; Dabek J
Pol Merkur Lekarski; 2011 Jan; 30(175):10-8. PubMed ID: 21542238
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes after coronary bare-metal-stent and drug-eluting-stent implantations: a 'real-world' comparison among patients with diabetes with diffuse small vessel coronary artery disease.
Koh AS; Chia S; Choi LM; Sim LL; Chua TS; Koh TH; Tan JW
Coron Artery Dis; 2011 Mar; 22(1):96-9. PubMed ID: 21164343
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome after bare-metal or drug-eluting stenting for allograft coronary artery disease.
Beygui F; Varnous S; Montalescot G; Fernandez F; Collet JP; Leprince P; Le Feuvre C; Pavie A; Komajda M; Metzger JP; Gandjbakhch I
J Heart Lung Transplant; 2010 Mar; 29(3):316-22. PubMed ID: 19837605
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications.
Qasim A; Cosgrave J; Latib A; Colombo A
Am J Cardiol; 2007 Dec; 100(11):1619-24. PubMed ID: 18036358
[TBL] [Abstract][Full Text] [Related]
20. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
